Similar articles

• Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.

  Gao L, Mann GE. Gao L, et al. Cardiovasc Res. 2009 Apr 1;82(1):9-20. doi: 10.1093/cvr/cvp031. Epub 2009 Jan 29. Cardiovasc Res. 2009. PMID: 19179352 Review.
• Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects.

  Camera A, Hopps E, Caimi G. Camera A, et al. Minerva Endocrinol. 2007 Sep;32(3):209-29. Minerva Endocrinol. 2007. PMID: 17912158 Review. English, Italian.
• Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes.

  Ceriello A. Ceriello A. Curr Opin Lipidol. 2006 Oct;17(5):510-8. doi: 10.1097/01.mol.0000245256.17764.fb. Curr Opin Lipidol. 2006. PMID: 16960499 Review.
• [Role of oxidative stress in pathogenesis of diabetic microangiopathies].

  Araki E, Nishikawa T. Araki E, et al. Nihon Rinsho. 2005 Jun;63 Suppl 6:73-8. Nihon Rinsho. 2005. PMID: 15999688 Review. Japanese. No abstract available.
• [Pathogenesis and prevention diabetes mellitus vascular complications].

  Balabolkin MI, Kreminskaia VM. Balabolkin MI, et al. Ter Arkh. 1999;71(10):5-12. Ter Arkh. 1999. PMID: 10612165 Review. Russian. No abstract available.